Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 1300
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00301093 | Vaccine Therapy and Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia | ||
| NCT06518551 | Elotuzumab + Iberdomide + Dexamethasone Post Ide-Cel in RRMM | ||
| NCT00890500 | Safety and Efficacy of ProHema Modulated Umbilical Cord Blood Units in Subjects With Hematologic Malignancies. | ||
| NCT00545792 | Safety Study Of Avastin And Pelvic Radiation In Women With Recurrent Gynecological Cancers | ||
| NCT00374257 | UVB Phototherapy Treatment of Oral Chronic GVHD | ||
| NCT01740219 | Promoting Organizational Capacity to Implement Cancer Control Programs Among Latino Churches | ||
| NCT04485767 | RESIST-ADT (Androgen Deprivation Therapy) | ||
| NCT02853500 | Effect of Surefire Infusion Device on Tumor Response to Regional Intra-arterial Therapy for Primary Liver Malignancies | ||
| NCT01181271 | Tandem Auto-Allo Transplant for Lymphoma | ||
| NCT00880334 | Randomized Study of Docetaxel +/- Vandetanib in Metastatic TCC | ||
| NCT05168930 | Zanubrutinib and Venetoclax in CLL (ZANU-VEN) | ||
| NCT07446647 | Comparative Analysis of Biotinylated, Irradiated and 51-Chromium Radiolabeled Red Blood Cells for Analysis of Recovery and Survival After Autologous Transfusion | ||
| NCT00361244 | SU011248 in Combination With Irinotecan and Cetuximab as a Second Line Regimen for Stage IV Colorectal Cancer | ||
| NCT06854003 | BRAZAN: A Randomized Phase 2 Study of Bendamustine, Rituximab, Cytarabine (AraC) Induction With Zanubrutinib (BRAZAN) Followed by Zanubrutinib/Rituximab +/- Sonrotoclax Maintenance in Treatment-Naïve Mantle Cell Lymphoma | ||
| NCT01955395 | Genomic and Psychosocial Effects of the 3RP on Patients With MGUS and Smoldering Multiple Myeloma | ||
| NCT04584255 | Niraparib + Dostarlimab In BRCA Mutated Breast Cancer | ||
| NCT05463848 | Surgical Pembro +/- Olaparib w TMZ for rGBM | ||
| NCT00418093 | Oxaliplatin, Gemcitabine and Bevacizumab in Women With Recurrent Mullerian Carcinoma | ||
| NCT02375776 | Improving Outcomes in Cancer Patients on Oral Anti-Cancer Medications Using a Multi-modal Mobile Health Intervention | ||
| NCT00307736 | Bevacizumab, Erlotinib and 5-Fluorouracil With External Beam Radiation Therapy in Locally Advanced Rectal Cancer | ||
| NCT01066663 | Pyrimethamine for the Treatment of Relapsed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | ||
| NCT03244826 | Shared Care: Patient-Centered Management After Hematopoietic Cell Transplantation | ||
| NCT05296512 | Pembrolizumab and Lenvatinib in Clear Cell Ovarian Cancer | ||
| NCT03654716 | Phase 1 Study of the Dual MDM2/MDMX Inhibitor ALRN-6924 in Pediatric Cancer | ||
| NCT00140504 | Preventing Adverse Drug Events With PatientSite | ||
| NCT07123649 | Individualizing Approaches to Surveillance Mammography in Older Breast Cancer Survivors - The I-MAMMO Study | ||
| NCT02261649 | Impact of Cerebellar Mass Resection on Pain Processing | ||
| NCT00580333 | Preoperative Cisplatin and Bevacizumab in ER-, PR-, HER2 Negative Breast Cancer | ||
| NCT05837884 | Predicting Progression of Developing Myeloma in a High-Risk Screened Population and General Population | ||
| NCT00200161 | Temozolomide & RT Followed by Dose Dense vs Temozolomide & Retinoic Acid in Pts w/Glioblastoma | ||
| NCT02950766 | NeoVax Plus Ipilimumab in Renal Cell Carcinoma | ||
| NCT04468061 | Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC | ||
| NCT01239394 | Ofatumumab for Initial Systemic Treatment of Indolent B-cell Lymphoma | ||
| NCT03717402 | Smartphone Technology to Alleviate Malignant Pain (STAMP) | ||
| NCT06805617 | A Phase 2 Trial of Ivonescimab for Patients With Advanced, Metastatic Salivary Gland Cancers | ||
| NCT00578240 | Molecular Studies and Clinical Correlations in Human Prostatic Disease | ||
| NCT02502695 | A Study to Optimize Care for Lung Cancer Patients Undergoing Video-Assisted Thoracoscopic Surgery (VATS) | ||
| NCT02756390 | CBTI-CS: A Novel Cognitive-Behavioral Treatment for Insomnia in Cancer Survivors | ||
| NCT00137761 | Docetaxel in Combination With Iressa in Previously Treated Patients With Pancreatic Cancer | ||
| NCT03277469 | Optimizing Brachytherapy Application and Delivery With MRI Guidance for Gynecologic Cancer | ||
| NCT00856180 | Sequential Angiogenic Blockade for the Treatment of Recurrent Mullerian Malignancies | ||
| NCT00165282 | Mindfulness Meditation in Bone Marrow Transplantation | ||
| NCT04900623 | Risk-adapted Therapy in HPV+ Oropharyngeal Cancer Using Circulating Tumor (ct)HPV DNA Profile - The ReACT Study | ||
| NCT06278896 | Early Neutropenic Fever De-escalation of Antibiotics Study | ||
| NCT06122896 | Prospective Screening for Pancreatic Ductal Adenocarcinoma in High-Risk Individuals | ||
| NCT04425018 | MARGetuximab Or Trastuzumab (MARGOT) | ||
| NCT04290546 | CIML NK Cell in Head & Neck Cancer | ||
| NCT01148056 | Intensity Modulated Radiation Therapy (IMRT) for Patients With Rectal Cancer | ||
| NCT03417739 | A Phase II Study of BVD-523 in Metastatic Uveal Melanoma | ||
| NCT00116506 | Study of Bevacizumab, Erlotinib, FOLFOX for Patients With Untreated Metastatic Colorectal Cancer |
